Product Information

IBANDRONATE SODIUM 150 MG TAB is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $2.7472 per EA under NDC 55111057543. Its NADAC has been published 244 times since Mar 23, 2022.

FDA first approved this application on Apr 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBANDRONATE SODIUM 150 MG TAB

Ibandronate sodium
$2.7472per EA

Strength

150 mg/1

NDC

55111057543

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IBANDRONATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA078997

FDA Approved

4/30/2012

TE Code

AB

On Market Since

6/21/2012

Pharmacological Classes

Bisphosphonate
Diphosphonates

Price Statistics

The NADAC for IBANDRONATE SODIUM 150 MG TAB has been published 244 times since Mar 23, 2022, and over the history we have for it it has declined 49.8%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7472 per EA
All-time high$5.9789 (Jul 13, 2022)
All-time low$2.6751 (Sep 23, 2026)
52-week high$2.9512
52-week low$2.6751
Median price$3.6858
Average price$3.8348
Largest weekly change-37.5% (Nov 20, 2024)
Weeks tracked244
Tracking sinceMar 23, 2022

Price History

1W

-0.7%

1M

+2.7%

3M

-0.2%

6M

-2.2%

1Y

-8.5%

3Y

-35.5%

5Y

N/A

All

-49.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IBANDRONATE SODIUM 150 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for IBANDRONATE SODIUM 150 MG TAB, manufactured by Dr. Reddy's Laboratories Inc., is $2.7472 per EA (NDC 55111057543), effective Nov 18, 2026.

How has the price of IBANDRONATE SODIUM 150 MG TAB changed over time?

Over the history we have for it, the NADAC for IBANDRONATE SODIUM 150 MG TAB has declined 49.8%. It has been tracked across 244 weekly CMS publications since Mar 23, 2022.

What are the highest and lowest recorded NADAC prices for IBANDRONATE SODIUM 150 MG TAB?

Since Mar 23, 2022, the NADAC for IBANDRONATE SODIUM 150 MG TAB has ranged from a low of $2.6751 (Sep 23, 2026) to a high of $5.9789 (Jul 13, 2022), with a median of $3.6858 per EA.

Are there cheaper alternatives to IBANDRONATE SODIUM 150 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as IBANDRONATE SODIUM 150 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures IBANDRONATE SODIUM 150 MG TAB?

IBANDRONATE SODIUM 150 MG TAB (NDC 55111057543) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.